Chemotherapeutic Assay Selects Effective Treatments for Ovarian Cancer Chemotherapy regimens chosen by the ChemoID assay dramatically increased ORR in patients with platinum-resistant ovarian cancer.

ChemoID assay picks the winning chemo! Dramatically improved ORR in platinum-resistant ovarian cancer patients by tailoring treatment. Precision in action! #OvarianCancer #ChemoID #CancerResearch #PlatinumResistant #TCSC #OncologyBreakthrough

www.oncnursingnews.com/view/chemoth...